Medical Device Variance Renewal - Redhouse Productions
Summary
FDA CDRH approved a variance renewal for Redhouse Productions (FDA-2023-V-2753-0004). The variance allows deviation from standard medical device manufacturing requirements under specific conditions. The renewal maintains previously granted flexibilities for the regulated entity.
What changed
FDA's Center for Devices and Radiological Health (CDRH) has renewed a variance for Redhouse Productions under docket FDA-2023-V-2753-0004. The variance permits the facility to operate under modified regulatory requirements for medical device manufacturing. The document confirms continuation of previously approved manufacturing deviations or alternative compliance arrangements.
Redhouse Productions should maintain all conditions specified in the variance approval and ensure continued compliance with any modified requirements. The facility should retain documentation of this renewal for inspection purposes. No new compliance deadlines or reporting requirements are imposed beyond existing variance conditions.
Source document (simplified)
Content
There are no documents available to view or download
Attachments 1
Variance Renewal from Redhouse Productions
More Information
- Author(s) CDRH
Download
CFR references
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.